Figures
Citation: Bertzbach LD, Kapischke T, Kaderali L, Pfaender S, Ip W-H (2026) Mind the gap between RNA and protein levels: A general phenomenon with implications for virology. PLoS Pathog 22(7): e1014470. https://doi.org/10.1371/journal.ppat.1014470
Editor: Siyuan Ding, Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine, UNITED STATES OF AMERICA
Published: July 30, 2026
Copyright: © 2026 Bertzbach et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Work in the authors’ labs was funded by Horizon Europe (DEFENDER, grant agreement 101191666 (to L.K and S.P.)), the Deutsche Forschungsgemeinschaft (DFG/German Research Foundation, grant numbers 462165342 (to L.K and S.P.), 518707518 (to S.P.), and 553707811 (to W.-H.I.)), as well as the Wilhelm Sander Foundation (grant number R2024.123.1 (to W.-H.I.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Accurate interpretation of gene expression during viral infection often relies on transcriptomic measurements, yet in both cell biology and virology it is now well established that RNA abundance is an imperfect proxy for protein levels. Early large-scale efforts to quantify gene expression, such as the landmark study by Schwanhäusser and colleagues, revealed that translation and protein degradation dominate steady-state protein abundance, sparking extensive debate and reanalysis [1]. Subsequent work refined these estimates, showing that while RNA contributes substantially, RNA-protein correlations are typically moderate and highly gene-specific, with transcript-protein relationships often showing only modest linear association (Pearson correlation coefficient r frequently around 0.5 or lower), meaning that mRNA levels only partially predict protein abundance [2–6]. Conceptual syntheses established that translation efficiency and protein stability are among the primary determinants of protein abundance, a view reinforced by gene-resolved analyses demonstrating that some transcripts closely track protein levels, whereas others are almost entirely decoupled [7].
These principles extend, and are frequently hijacked and amplified, during viral infection, enabling viruses to rewire host gene expression by decoupling RNA abundance from protein output to promote replication and evade immune detection. In virology, while transcriptional regulation sets the initial RNA pool, protein abundance is ultimately shaped by a cascade of post-transcriptional and post-translational mechanisms, including translation efficiency, RNA stability, translational control, and protein degradation, highlighting the nonlinear relationship between RNA and protein levels. Multi-omics and translational profiling studies across diverse viral systems consistently demonstrate that RNA abundance incompletely predicts protein output during infection. In human cytomegalovirus (HCMV) infection, quantitative temporal viromics reveals strong divergence between transcript and protein dynamics across both viral and host systems, with distinct temporal waves of protein expression that are only partially reflected at the RNA level, highlighting extensive post-transcriptional and post-translational regulation [8]. Extending this framework, transcriptomic analyses of HCMV gene expression during lytic and latent infection show that viral transcription is not governed by a simple linear cascade, but instead by multiple independently regulated gene modules. Rather than a strictly sequential program, viral genes are controlled through layered regulatory inputs, and latency is characterized by a distinct repression of immediate-early genes, redefining classical models of HCMV gene regulation and underscoring fundamentally different transcriptional control logic between infection states [9]. This layered regulatory logic, characterized by asynchronous activation and state-specific repression (e.g., of immediate-early genes during latency), results in nonuniform RNA accumulation, contributing to the poor correlation between RNA and protein levels even before translation or degradation is considered.
In SARS-CoV-2-infected cells, mapping of the viral RNA-protein interactome reveals that both viral and host RNAs form extensive, dynamic complexes with host RNA-binding proteins (RBPs) and viral proteins, collectively shaping the functional fate of transcripts. This indicates that RNA abundance alone is insufficient to predict or explain downstream functional protein-level outcomes, as functional interpretation depends on the specific RNA-protein complexes formed during infection [10]. Similarly, ribosome-associated translation remodeling during Dengue virus infection demonstrates that viral infection can selectively reprogram endoplasmic reticulum-associated translation machinery, leading to substantial discordance between RNA abundance and ribosome engagement, and therefore between transcript levels and protein synthesis output [11]. This decoupling is further reinforced by recent systems-level analyses of viral gene expression programs. In HIV-1 infection, global translational profiling shows that extensive RNA diversity generated through splicing and processing is subject to strong post-transcriptional filtering, such that only a subset of transcripts is productively translated into protein [12]. Likewise, during vaccinia virus infection, integrated proteomic and transcriptomic analyses reveal widespread gene-specific discordance between RNA and protein kinetics, underscoring dominant roles for translational control and protein stability in shaping the viral proteome [13].
Collectively, these observations argue that RNA-protein discordance is not experimental noise but a fundamental feature of gene expression regulation, driven by layered control at the levels of transcription, translation, and RNA/protein stability.
1. RNA abundance is only loosely predictive of viral protein levels
Transcriptomic data alone fail to reliably predict protein expression, as many genes exhibit low or no correlation, delayed responses, inverse relationships, or inconsistent coupling between RNA and protein levels [14]. Viral genes are particularly prone to decoupling due to temporal expression programs, polycistronic mRNAs, nested open reading frames, programmed ribosomal frameshifting, or compartmentalized replication. Alternative splicing and RNA modifications (such as m6A methylation) further diversify the transcriptome, generating multiple protein isoforms from a single gene or altering RNA stability, localization, and translation efficiency [15]. Translation of viral RNA is tightly coupled to, and often impeded by, RNA replication, and ribosomes can stall or displace replication complexes, creating a kinetic conflict that delays protein synthesis and contributes to RNA-protein discordance [16]. The distribution of RNA, translation, and protein abundance differs significantly, with replication compartments further distorting local RNA levels. Critically, assembled virions, usually containing one genome copy but numerous proteins, can accumulate intracellularly with long half-lives, skewing total RNA and protein measurements toward nonfunctional, stored material – such as mature virions that are not actively translating or replicating but persist in the cell. Thus, RNA-seq alone cannot define functional viral or host output [17]. The disconnect between RNA and protein levels is not merely a consequence of measurement artifacts, but is actively shaped: post-transcriptional mechanisms including microRNA-mediated silencing, RNA decay, and translational repression play a central role in shaping protein output [18]. Host cells deploy these pathways to target viral mRNAs for degradation or translational arrest, often through post-transcriptional gene silencing mediated by cellular or viral miRNAs. In parallel, RNA-protein complexes such as stress granules and P-bodies act as hubs for RNA storage, decay, and translational control, sequestering viral transcripts and limiting their expression [19,20]. Therefore, this discordance is not technical noise but reflects biological regulation, as demonstrated by multi-omics studies showing poor correlation between transcription and translation in infected cells.
2. Translation is a primary control point reshaped by infection
Viral infections frequently reprogram translation, inducing global host shutoff while selectively promoting viral mRNA translation via mechanisms such as cap-snatching, IRES-driven initiation, ribosome hijacking, or ribosomal pausing. These strategies allow viruses to prioritize their own protein synthesis despite host translational suppression. The ribosome, not the transcriptome, often determines infection phenotypes, as translation efficiency can override RNA abundance. For example, influenza virus uses cap-snatching to initiate viral mRNA translation, while other viruses exploit altered ribosome dynamics to favor viral over host protein production [21,22]. Notably, some viruses use specialized ribosomes (modified with unique ribosomal proteins or post-translational modifications) to translate viral mRNAs within virus-induced organelles [23]. Functional studies have shown that RPS25 is selectively recruited to the 40S ribosomal subunit during IRES-mediated initiation, enabling translation of viral mRNAs [24]. Viruses subvert these ribosomal features to enhance translation efficiency and evade host surveillance. This translational reprogramming underscores that protein levels are not dictated by RNA abundance alone, but by active, virus-driven control of the translation machinery.
3. Some viral life cycles intentionally decouple RNA and protein timing
Many viruses use temporal decoupling to optimize infection: early genes (e.g., regulatory proteins) are translated from low-abundance RNAs to generate potent protein bursts, while late structural genes accumulate RNA in advance, with translation delayed until assembly is ready. This allows for efficient coordination of replication and virion formation. For instance, herpesviruses employ multiple independently regulated temporal modules, with gene expression not strictly tied to classical transcriptional cascades [9]. In such cases, RNA abundance reflects “stored potential” rather than immediate function, highlighting that temporal regulation is a key viral strategy to maximize fitness and evade host defenses. Host cells deploy the nonsense-mediated decay (NMD) pathway as a frontline defense, targeting aberrant or foreign mRNAs for degradation. In response, viruses have evolved counterstrategies: they either induce NMD to eliminate host antiviral transcripts or modify their own RNAs to evade recognition, such as by altering 3′ UTRs or splicing patterns [25]. This ongoing molecular contest, where host surveillance shapes viral evolution and viral evasion reshapes host defenses, again demonstrates that RNA-protein discordance is not noise, but a functional signature of a dynamic host-pathogen interaction.
4. Post-translational regulation dominates protein abundance outcomes
Protein abundance is as much a product of degradation as of synthesis. Viruses actively manipulate host degradation pathways—degrading antiviral proteins while stabilizing viral proteins to prolong their functional lifespan. Host mRNA shutoff (e.g., via viral endonucleases or indirectly, by activation of cellular RNA degradation pathways) leads to rapid decline in host protein synthesis, while viral proteins may be stabilized through post-translational modifications or interactions with host factors [26]. For example, SUMOylation of viral proteins can alter their localization (and stability), with cascading effects on host proteostasis [27]. Accordingly, post-translational regulation, including targeted degradation, is a major driver of protein abundance changes during infection – and protein levels are not simply a reflection of transcription/RNA levels but a dynamic balance between synthesis and degradation.
5. RNA-protein discordance reflects biological regulation, not experimental noise!
Discrepancies between RNA and protein levels are not artifacts but meaningful regulatory features shaped by evolution, host defense, and viral countermeasures. They reflect temporal phase offsets, selective translation, and compartmentalization, strategies that optimize infection efficiency (while host cells attempt to counteract this by downregulating translation globally or targeting specific viral mRNAs for degradation, ultimately aiming to limit viral replication and spread). RBPs and noncoding RNAs (ncRNAs), for example, play a central role in this regulation, modulating RNA stability, localization, and translation in response to infection [28–30]. These mechanisms allow viruses to fine-tune protein expression without altering transcription, enabling rapid adaptation. Discordance is therefore not noise but a functional signature of infection, revealing layers of post-transcriptional control that are critical for viral fitness and host-pathogen interactions. Recognizing this is essential for interpreting omics data and understanding true biological function.
Take home message
Taken together, RNA-protein discordance in general as well as in viral infection systems should not be viewed as a limitation of transcriptomics, but as a hallmark of multilayered post-transcriptional as well as post-translational regulation. While discrepancies between RNA and protein levels have historically been attributed to technical variability—such as differences in detection sensitivity or data analysis—recent multi-omics studies reveal that this divergence is largely biological, not technical. The growing body of evidence shows that transcript-protein uncoupling is widespread, driven by dynamic processes including transcriptional and translational control, selective protein degradation, viral hijacking of ribosomes, and the accumulation of nonfunctional, packaged viral components. These mechanisms (e.g., delayed translation of late viral genes, RBP and ncRNA-mediated RNA regulation, and compartmentalization of replication and translation) allow viruses to fine-tune protein output independently of RNA abundance (Fig 1, Table 1). Assembled virions, with their long half-lives and high protein-to-RNA ratios, further distort total abundance measurements, emphasizing that high RNA or protein levels do not equate to functional activity. Thus, RNA levels alone are insufficient to predict biological outcomes. Instead, in silico models should explicitly incorporate transcriptional, translational, post-transcriptional, and post-translational regulatory processes, while in vitro and in vivo studies should integrate transcriptomic measurements with direct assessments of protein abundance and function and move beyond transcript-centric biases. Rather than viewing RNA-protein discordance as noise across the continuum from gene induction to functional protein responses, it should be recognized as a key indicator of dynamic regulatory mechanisms including post-transcriptional and translational regulation, as well as protein stability. Understanding this gap is not about correcting data, but about uncovering the true process of infection, where biological function emerges not only from RNA abundance, but also from the precise spatiotemporal control of protein synthesis and stability.
Schematic and simplified time course of viral RNA, protein, and functional output (e.g., infectious particle production or reporter activity) following infection. All values are normalized to the maximum observed level for each component to enable direct comparison across molecules. RNA shows an early peak, reflecting rapid transcription. Protein accumulates with a delay, consistent with translation kinetics. The functional output generally closely parallels the protein curve, indicating that biological activity is limited by protein abundance and maturation rather than RNA levels. Importantly, assembled virions (containing one RNA copy but many proteins) may accumulate intracellularly and persist with long half-lives, contributing to elevated total protein and RNA signals without reflecting active gene expression. This can artificially inflate abundance measurements and obscure true regulatory dynamics. Thus, the strong correlation between protein and functional output, despite the RNA-protein gap, underscores the importance of measuring biologically active output rather than total abundance alone.
Acknowledgments
As we stand on the shoulders of giants, we acknowledge the significant contributions of researchers who have studied RNA-protein discordance (in virology and beyond). Their work has laid the foundation for our understanding of this complex phenomenon. Due to format constraints, we have had to selectively cite relevant literature, omitting many worthy papers. We acknowledge the contributions of these authors and recognize the value of their work, even if not explicitly cited.
References
- 1. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337–42. pmid:21593866
- 2. Li JJ, Bickel PJ, Biggin MD. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ. 2014;2:e270. pmid:24688849
- 3. Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535–50. Epub 2016/04/23. pmid:27104977
- 4. Ponomarenko EA, Krasnov GS, Kiseleva OI, Kryukova PA, Arzumanian VA, Dolgalev GV, et al. Workability of mRNA sequencing for predicting protein abundance. Genes (Basel). 2023;14(11). Epub 20231111. pmid:38003008
- 5. Srivastava H, Lippincott MJ, Currie J, Canfield R, Lam MPY, Lau E. Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners. PLoS Comput Biol. 2022;18(11):e1010702. pmid:36356032
- 6. Deangeli G, Spillantini MG, Lio P. Proteomizer: leveraging the transcriptome-proteome mismatch to infer novel gene regulatory relations. bioRxiv. 2025. pmid:40666834
- 7. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227–32. pmid:22411467
- 8. Weekes MP, Tomasec P, Huttlin EL, Fielding CA, Nusinow D, Stanton RJ, et al. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell. 2014;157(6):1460–72. pmid:24906157
- 9. Rozman B, Nachshon A, Levi Samia R, Lavi M, Schwartz M, Stern-Ginossar N. Temporal dynamics of HCMV gene expression in lytic and latent infections. Cell Rep. 2022;39(2):110653. pmid:35417700
- 10. Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, et al. The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat Microbiol. 2021;6(3):339–53. pmid:33349665
- 11. Reid DW, Campos RK, Child JR, Zheng T, Chan KWK, Bradrick SS, et al. Dengue virus selectively annexes endoplasmic reticulum-associated translation machinery as a strategy for co-opting host cell protein synthesis. J Virol. 2018;92(7):e01766-17. pmid:29321322
- 12. Kibe A, Buck S, Gribling-Burrer A-S, Gilmer O, Bohn P, Koch T, et al. The translational landscape of HIV-1 infected cells reveals key gene regulatory principles. Nat Struct Mol Biol. 2025;32(5):841–52. pmid:39815046
- 13. Matía A, McCarthy F, Woosley H, Turon-Lagot V, Platzer SW, Liu J, et al. Spatio-temporal analysis of Vaccinia virus infection and host response dynamics using single-cell transcriptomics and proteomics. bioRxiv. 2024.
- 14. Zhao H, Chen M, Valdés A, Lind SB, Pettersson U. Transcriptomic and proteomic analyses reveal new insights into the regulation of immune pathways during adenovirus type 2 infection. BMC Microbiol. 2019;19(1):15. pmid:30642258
- 15. Manners O, Baquero-Perez B, Whitehouse A. m6A: widespread regulatory control in virus replication. Biochim Biophys Acta Gene Regul Mech. 2019;1862(3):370–81. pmid:30412798
- 16. Gamarnik AV, Andino R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 1998;12(15):2293–304. pmid:9694795
- 17. Beliakova-Bethell N, Manousopoulou A, Deshmukh S, Mukim A, Richman DD, Garbis SD, et al. Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency. Virology. 2022;573:50–8. pmid:35714458
- 18. Bernier A, Sagan SM. The diverse roles of microRNAs at the host–virus interface. Viruses. 2018;10(8):440. pmid:30126238
- 19. Reineke LC, Lloyd RE. Diversion of stress granules and P-bodies during viral infection. Virology. 2013;436(2):255–67. pmid:23290869
- 20. Zhang Q, Sharma NR, Zheng Z-M, Chen M. Viral regulation of RNA granules in infected cells. Virol Sin. 2019;34(2):175–91. pmid:31037644
- 21. Rozman B, Fisher T, Stern-Ginossar N. Translation-A tug of war during viral infection. Mol Cell. 2023;83(3):481–95. pmid:36334591
- 22. Banerjee AK, Blanco MR, Bruce EA, Honson DD, Chen LM, Chow A, et al. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell. 2020;183(5):1325-1339.e21. pmid:33080218
- 23. Walsh D, Mohr I. Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol. 2011;9(12):860–75. pmid:22002165
- 24. Hertz MI, Landry DM, Willis AE, Luo G, Thompson SR. Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting. Mol Cell Biol. 2013;33(5):1016–26. pmid:23275440
- 25. Leon K, Ott M. An ‘Arms Race’ between the Nonsense-mediated mRNA Decay Pathway and Viral Infections. Semin Cell Dev Biol. 2021;111:101–7. pmid:32553580
- 26. Walter Z, Li M, Molho M, Berish L, Isopi A, O’Mara M, et al. An integrated proteomics approach identifies phosphorylation sites on viral and host proteins that regulate West Nile virus infection. Cell Rep. 2025;44(5):115728. pmid:40381193
- 27. Ip W-H, Tatham MH, Krohne S, Gruhne J, Melling M, Meyer T, et al. Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors. J Virol. 2023;97(11):e0079123. pmid:37916833
- 28. Anastassopoulou C, Panagiotopoulos A-P, Siafakas N, Tsakris A. The potential of RNA-binding proteins as host-targeting antivirals against RNA viruses. Int J Antimicrob Agents. 2025;66(2):107522. pmid:40258479
- 29. Zhang D, Zhang M, Zhang L, Wang W, Hua S, Zhou C, et al. Long non-coding RNAs and immune cells: unveiling the role in viral infections. Biomed Pharmacother. 2024;170:115978. pmid:38056234
- 30. Yamin M, Alsahafi N, Abdulal RH, Asad M, Bosaeed M, Zohaib A. Non-coding RNAs in the viral host-pathogen interaction: molecular regulation and therapeutic potential. Front Cell Infect Microbiol. 2025;15:1734182. pmid:41488474